Expanding horizons: Tempus AI’s sequencing and data capabilities in Japan

Discover how our Japan lab, advanced assays, and localized data strategy streamline global trials and accelerate companion diagnostic development in the Japanese market.

Aug 25, 2026
Life Sciences
Webinar
Black and white portrait of a smiling woman with long dark hair looking forward.Kara WernerVP and General Manager, Life Sciences Sequencing, Tempus
Black and white headshot of an Asian man in a suit and tie.Tsuyoshi MitsuhashiRepresentative Director and President, GenMine Labs Corp.
Black and white portrait of a young Asian man in a suit.Shijun Jo Head of Life Science Solution, SB TEMPUS Corp.
Black and white headshot of a woman with long hair looking directly at the viewer.Nike Beaubier, MDSenior Vice President, Life Science Pathology, Tempus

Session highlights

  • Get an inside look at our state-of-the-art Tokyo facility, current assay portfolio, and upcoming diagnostic developments.

  • Learn how we partner with international biopharma companies to optimize global clinical trials, and can accelerate companion diagnostics (CDx) within the Japanese market.

  • Discover our strategic roadmap for data acquisition in Japan and how it fuels precision medicine.